Pharmaceutical Combination comprising an Antibody that specifically recognizes to CD38, and Cyclophosphamide, where the Antibody is capable of eliminating a CD38 + cells by apoptosis, Antibody dependent cell-mediated cytotoxicity (ADCC) and complement dependent cytotoxicity (CDC).

• 收藏
• 分享

专利权人:

SANOFI

发明人:

LEJEUNE PASCALE,VRIGNAUD PATRICIA

申请号：

CL2011001256

公开号：

CL2011001256A1

申请日:

2011.05.27

申请国别(地区):

CL

年份:

2012

代理人:

摘要：

Pharmaceutical combinations comprising an Antibody that specifically recognizes at least CD38 and Cyclophosphamide； and use of CD38 Antibody that recognizes specifically for the treatment of squamoR.<；p>；Combinaciones farmacé；utica que comprende un anticuerpo que reconoce especí；ficamente cd38 y al menos ciclofosfamida； y uso del anticuerpo que reconoce especí；ficamente cd38 para el tratamiento del cá；ncer.<；/p>；

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/